Dimensional Fund Advisors
JBIO

Dimensional Fund Advisors’s Jade Biosciences JBIO Stock Holding History

Dimensional Fund Advisors’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-302
Closed -$22.1K – 3343
2024
Q3 		$22.1K Sell
302
-30
-9% -$1.94K ﹤0.01% 3331
2024
Q2 		$19.3K Sell
332
-95
-22% -$63K ﹤0.01% 3352
2024
Q1 		$442K Hold
427
– – ﹤0.01% 3065
2023
Q4 		$339K Sell
427
-160
-27% -$81.5K ﹤0.01% 3107
2023
Q3 		$279K Sell
587
-128
-18% -$69.3K ﹤0.01% 3151
2023
Q2 		$428K Buy
715
+383
+115% +$245K ﹤0.01% 3096
2023
Q1 		$234K Buy
+332
New +$275K ﹤0.01% 3172

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
AI
Allostery Investments Stamford, Connecticut $7.85M AUM

Dimensional Fund Advisors's JBIO Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of Jade Biosciences (JBIO) in Q4 2024, closing a stake of 302 shares — an estimated $22.1K sold.

Dimensional Fund Advisors first reported a position in JBIO in Q1 2023 and held it in 7 quarters. The position peaked at $442K in Q1 2024. 78 funds tracked by Wall St. Rank hold JBIO as of Q4 2024.

  • Dimensional Fund Advisors reported no remaining Jade Biosciences position as of Q4 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 302 Jade Biosciences shares in Q4 2024, an estimated $22.1K.
  • Dimensional Fund Advisors first reported a position in Jade Biosciences in Q1 2023 and held it in 7 quarters.
  • Dimensional Fund Advisors's Jade Biosciences position peaked at $442K in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Jade Biosciences as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.